Sequence information


DRAVP ID  DRAVPc010

Name   Golotimod

Sequence 

Molecular Formula  C16H19N3O5

Condition/Disease  Chronic HCV infection

Group  Phase â…¡clinical trial

Type  Peptide

Description  Golotimod(SCV-07) is a novel synthetic dipeptide containing the amino acids D-glutamine and L-tryptophan, which is used to treat hepatitis C by oral administration. SCV-07 has shown efficacy in treating various viral and bacterial infections.

Active sequence/Structure 


External Links


DrugBank Accession Number  DB05475

Pubchem ID  6992140

CHEMBL ID  CHEMBL2103812

UNII  637C487Y09

CAS  229305-39-9

Reference  34258744 



ClinicalTrails Information


NCT Number Study Title Condition/Disease Status Phase Sponsor
NCT00968357 Proof-of-concept Study to Evaluate the Safety and Immunomodulatory Effects of SCV 07 as Monotherapy or in Combination With Ribavirin in Noncirrhotic Subjects With Chronic Hepatitis C Who Have Relapsed Chronic Hepatitis C virus infection Completed Phase 2 SciClone Pharmaceuticals